Skip to main content

Table 1 Primary conditions treated with medicinal cannabis

From: Medical cannabis patterns of use and substitution for opioids & other pharmaceutical drugs, alcohol, tobacco, and illicit substances; results from a cross-sectional survey of authorized patients

Primary conditions Total: n (%) Male: n (%) Female: n (%) Unspecified: n (%)
Total study population 2032 1271 (62.6%) 758 (37.3%) 3 (0.15%)
Chronic pain 598 (29.4%) 371 (62%) 227 (38%)  
Mental health condition 548 (27%) 319 (58.2%) 228 (41.6%) 1 (0.2%)
Insomnia 198 (9.7%) 145 (73.2%) 53 (26.8%)  
Arthritis/musculoskeletal 188 (9.3%) 112 (59.6%) 76 (40.4%)  
PTSD 93 (4.6%) 59 (63.4%) 33 (35.5%) 1 (1.1%)
Headache 75 (3.7%) 44 (58.7%) 31 (41.3)  
Gastrointestinal disorder 62 (3.1%) 34 (54.8%) 28 (45.2%)  
Multiple sclerosis 45 (2.2%) 26 (57.8%) 19 (42.2%)  
Other 38 (1.9%) 23 (60.5%) 15 (39.5%)  
Cancer/leukemia 35 (1.7%) 24 (68.6%) 11 (31.4%)  
Crohn’s disease 35 (1.7%) 27 (77.1%) 8 (22.9%)  
Brain injury 24 (1.3%) 16 (66.7%) 8 (33.3%)  
Epilepsy/seizure disorder 21 (1.0%) 18 (85.7%) 3 (14.3%)  
Eating disorder 20 (1.0%) 10 (50%) 10 (50%)  
Diabetes 16 (0.79%) 13 (81.3%) 3 (18.7%)  
Movement disorder 10 (0.49%) 8 (80%) 1 (10%) 1 (10%)
AIDS/HIV 8 (0.39%) 7 (87.5%) 1 (12.5%)  
Hepatitis 6 (0.30%) 6 (100%) 0 (0%)  
Glaucoma 5 (0.25%) 5 (100%) 0 (0%)  
Osteoporosis 4 (0.20%) 3 (75%) 1 (25%)  
Skin condition 3 (0.15%) 1 (33.3%) 2 (66.7%)